BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35084090)

  • 1. Assessment of efficacy in automated plan generation for Varian Ethos intelligent optimization engine.
    Pokharel S; Pacheco A; Tanner S
    J Appl Clin Med Phys; 2022 Apr; 23(4):e13539. PubMed ID: 35084090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of semi-automated stereotactic treatment planning for online adaptive radiotherapy in ethos.
    Byrne M; Archibald-Heeren B; Hu Y; Greer P; Luo S; Aland T
    Med Dosim; 2022 Winter; 47(4):342-347. PubMed ID: 36127189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse.
    Peters S; Schiefer H; Plasswilm L
    Radiat Oncol; 2014 Jul; 9():153. PubMed ID: 25011529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A head and neck treatment planning strategy for a CBCT-guided ring-gantry online adaptive radiotherapy system.
    Nasser N; Yang GQ; Koo J; Bowers M; Greco K; Feygelman V; Moros EG; Caudell JJ; Redler G
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14134. PubMed ID: 37621133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer.
    Calmels L; Sibolt P; Åström LM; Serup-Hansen E; Lindberg H; Fromm AL; Persson G; Sjöström D; Geertsen P; Behrens CP
    Tech Innov Patient Support Radiat Oncol; 2022 Jun; 22():30-36. PubMed ID: 35464888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating machine learning enhanced intelligent-optimization-engine (IOE) performance for ethos head-and-neck (HN) plan generation.
    Visak J; Inam E; Meng B; Wang S; Parsons D; Nyugen D; Zhang T; Moon D; Avkshtol V; Jiang S; Sher D; Lin MH
    J Appl Clin Med Phys; 2023 Jul; 24(7):e13950. PubMed ID: 36877668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of two treatment planning systems for spine SBRT.
    Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
    Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
    Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
    World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commissioning and dosimetric validation of a novel compensator-based Co-60 IMRT system for evaluating suitability to automated treatment planning.
    Oh K; Sengupta B; Olanrewaju A; Zhang L; Nair SS; Mani T; Palanisamy M; KanduKuri US; Netherton TJ; Cardenas CE; Court LE; Ford EC
    Med Phys; 2023 Jul; 50(7):4466-4479. PubMed ID: 37086040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
    Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
    J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of dose calculation accuracy during optimization on lung IMRT plan quality.
    Li Y; Rodrigues A; Li T; Yuan L; Yin FF; Wu QJ
    J Appl Clin Med Phys; 2015 Jan; 16(1):5137. PubMed ID: 25679172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
    Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
    J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of biological versus physical optimization for single-arc VMAT for prostate and head and neck cases.
    Pyshniak V; Fotina I; Zverava A; Siamkouski S; Zayats E; Kopanitsa G; Okuntsau D
    J Appl Clin Med Phys; 2014 Jul; 15(4):4514. PubMed ID: 25207394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.
    Pasler M; Georg D; Wirtz H; Lutterbach J
    Strahlenther Onkol; 2011 Dec; 187(12):792-8. PubMed ID: 22127357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated VMAT treatment planning using sequential convex programming: algorithm development and clinical implementation.
    Dursun P; Hong L; Jhanwar G; Huang Q; Zhou Y; Yang J; Pham H; Cervino L; Moran JM; Deasy JO; Zarepisheh M
    Phys Med Biol; 2023 Jul; 68(15):. PubMed ID: 37343584
    [No Abstract]   [Full Text] [Related]  

  • 17. An artificial intelligence-driven agent for real-time head-and-neck IMRT plan generation using conditional generative adversarial network (cGAN).
    Li X; Wang C; Sheng Y; Zhang J; Wang W; Yin FF; Wu Q; Wu QJ; Ge Y
    Med Phys; 2021 Jun; 48(6):2714-2723. PubMed ID: 33577108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of multi-criteria optimization (MCO) for volumetric modulated arc therapy (VMAT) in hippocampal avoidance whole brain radiation therapy (HA-WBRT).
    Zieminski S; Khandekar M; Wang Y
    J Appl Clin Med Phys; 2018 Mar; 19(2):184-190. PubMed ID: 29411526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of pulsed IMRT and VMAT for re-irradiation treatments: dosimetric and delivery feasibilities.
    Lin MH; Price RA; Li J; Kang S; Li J; Ma CM
    Phys Med Biol; 2013 Nov; 58(22):8179-96. PubMed ID: 24200917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?
    Quan EM; Chang JY; Liao Z; Xia T; Yuan Z; Liu H; Li X; Wages CA; Mohan R; Zhang X
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e69-76. PubMed ID: 22901421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.